n/a
Article Publish Status: FREE
Abstract Title:

Deguelin, a novel anti-tumorigenic agent targeting apoptosis, cell cycle arrest and anti-angiogenesis for cancer chemoprevention.

Abstract Source:

Mol Clin Oncol. 2013 Mar ;1(2):215-219. Epub 2012 Oct 18. PMID: 24649149

Abstract Author(s):

Ying Wang, Wenli Ma, Wenling Zheng

Article Affiliation:

Ying Wang

Abstract:

Deguelin is a natural compound of the flavonoid family products isolated fromLour. or(Leguminosae). It exhibited significant anti-tumorigenesis and anti-proliferative activity in various types of cancer bothand. Deguelin induced cell apoptosis by blocking anti-apoptotic pathways, such as PI3K-Akt, IKK-IκBα-NF-κB and AMPK-mTOR-survivin, while inhibiting tumor cell propagation and malignant transformation through p27-cyclinE-pRb-E2F1 cell cycle control and HIF-1α-VEGF anti-angiogenic pathways. In pre-clinical trials, deguelin markedly decreased the tumor incidence. These biological findings identified deguelin as a novel anti-tumorigenic agent targeting apoptosis, cell cycle arrest and anti-angiogenesis for cancer chemoprevention and chemotherapy.

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.